Xeureka Inc. uses the latest computational technology, including cutting-edge AI and simulations, to improve the efficiency and success rate of drug discovery research. We aim to contribute to the swift, economical delivery of effective medicines to patients suffering from disease.
Xeureka provides solutions for drug discovery research in the areas of both Dry (computational) and Wet (experimental) drug discovery. In addition to analysis and screening services, we plan to sell software and provide SaaS in the future. Please contact us to discuss how we can customize a solution to meet your needs, including the establishment of a computing environment.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Otemachi One, 1-2-1 Otemachi, Chiyoda-Ku, Tokyo, Chiyodaku,tokyo,japan
- Industry
- Information Services
- NAICS
-
Other Information ServicesNews SyndicatesAll Other Information Services
- Website
- https://xeureka.co.jp/
- HQ
- Chiyodaku, Tokyo
Xeureka Questions
Xeureka's website is https://xeureka.co.jp/
Xeureka's LinkedIn profile is https://jp.linkedin.com/company/xeureka
Xeureka has
7 employees.
View email and phone details for 7
employees at Xeureka.
Xeureka's industry is
Information Services
Xeureka's top competitors are
Chugai Pharmaceutical Co., Ltd.,
Auxilart Co., Ltd.,
株式会社エイシング,
Unravelx,
Tarowashimi,
Entaar,
Eas.ai Pte. Ltd.,
株式会社アークス／arcs Inc.,,
Agrodesign Studios,
Upward Indonesia.
Xeureka's categories are Information Services
Xeureka's founding year is 2021
